# Raltegravir

NDC: 70748-327
Generic name: Raltegravir
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20261014

FDA application: ANDA217990

## Active ingredients

- RALTEGRAVIR POTASSIUM: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70748-327"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70748-327